288 related articles for article (PubMed ID: 33384303)
1. Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for
Obeng S; Wilkerson JL; León F; Reeves ME; Restrepo LF; Gamez-Jimenez LR; Patel A; Pennington AE; Taylor VA; Ho NP; Braun T; Fortner JD; Crowley ML; Williamson MR; Pallares VLC; Mottinelli M; Lopera-Londoño C; McCurdy CR; McMahon LR; Hiranita T
J Pharmacol Exp Ther; 2021 Mar; 376(3):410-427. PubMed ID: 33384303
[TBL] [Abstract][Full Text] [Related]
2. Interactive Effects of
Obeng S; Leon F; Patel A; Zuarth Gonzalez JD; Chaves Da Silva L; Restrepo LF; Gamez-Jimenez LR; Ho NP; Guerrero Calvache MP; Pallares VLC; Helmes JA; Shiomitsu SK; Soto PL; McCurdy CR; McMahon LR; Wilkerson JL; Hiranita T
J Pharmacol Exp Ther; 2022 Dec; 383(3):182-198. PubMed ID: 36153006
[TBL] [Abstract][Full Text] [Related]
3. The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats.
Hiranita T; Leon F; Felix JS; Restrepo LF; Reeves ME; Pennington AE; Obeng S; Avery BA; McCurdy CR; McMahon LR; Wilkerson JL
Psychopharmacology (Berl); 2019 Sep; 236(9):2725-2734. PubMed ID: 31098655
[TBL] [Abstract][Full Text] [Related]
4. A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects.
Chakraborty S; DiBerto JF; Faouzi A; Bernhard SM; Gutridge AM; Ramsey S; Zhou Y; Provasi D; Nuthikattu N; Jilakara R; Nelson MNF; Asher WB; Eans SO; Wilson LL; Chintala SM; Filizola M; van Rijn RM; Margolis EB; Roth BL; McLaughlin JP; Che T; Sames D; Javitch JA; Majumdar S
J Med Chem; 2021 Sep; 64(18):13873-13892. PubMed ID: 34505767
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus properties of mitragynine (kratom) in rats.
Harun N; Hassan Z; Navaratnam V; Mansor SM; Shoaib M
Psychopharmacology (Berl); 2015 Jul; 232(13):2227-38. PubMed ID: 25616583
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa.
Matsumoto K; Horie S; Ishikawa H; Takayama H; Aimi N; Ponglux D; Watanabe K
Life Sci; 2004 Mar; 74(17):2143-55. PubMed ID: 14969718
[TBL] [Abstract][Full Text] [Related]
8. Orally active opioid μ/δ dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice.
Matsumoto K; Narita M; Muramatsu N; Nakayama T; Misawa K; Kitajima M; Tashima K; Devi LA; Suzuki T; Takayama H; Horie S
J Pharmacol Exp Ther; 2014 Mar; 348(3):383-92. PubMed ID: 24345467
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats.
Behnood-Rod A; Chellian R; Wilson R; Hiranita T; Sharma A; Leon F; McCurdy CR; McMahon LR; Bruijnzeel AW
Drug Alcohol Depend; 2020 Oct; 215():108235. PubMed ID: 32889450
[TBL] [Abstract][Full Text] [Related]
10. Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.
Hemby SE; McIntosh S; Leon F; Cutler SJ; McCurdy CR
Addict Biol; 2019 Sep; 24(5):874-885. PubMed ID: 29949228
[TBL] [Abstract][Full Text] [Related]
11. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
[TBL] [Abstract][Full Text] [Related]
12. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic Characterization of Substituted Nitazenes at
Kozell LB; Eshleman AJ; Wolfrum KM; Swanson TL; Bloom SH; Benware S; Schmachtenberg JL; Schutzer KA; Schutzer WE; Janowsky A; Abbas AI
J Pharmacol Exp Ther; 2024 Apr; 389(2):219-228. PubMed ID: 38453524
[TBL] [Abstract][Full Text] [Related]
14. Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.
Kruegel AC; Gassaway MM; Kapoor A; Váradi A; Majumdar S; Filizola M; Javitch JA; Sames D
J Am Chem Soc; 2016 Jun; 138(21):6754-64. PubMed ID: 27192616
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
Picker MJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970
[TBL] [Abstract][Full Text] [Related]
16. Abuse liability of mitragynine assessed with a self-administration procedure in rats.
Yue K; Kopajtic TA; Katz JL
Psychopharmacology (Berl); 2018 Oct; 235(10):2823-2829. PubMed ID: 30039246
[TBL] [Abstract][Full Text] [Related]
17. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice.
Thongpradichote S; Matsumoto K; Tohda M; Takayama H; Aimi N; Sakai S; Watanabe H
Life Sci; 1998; 62(16):1371-8. PubMed ID: 9585164
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of morphine-like effects of the mixed mu/delta agonist morphine-6-
Yadlapalli JSK; Bommagani SB; Mahelona RD; Wan A; Gannon BM; Penthala NR; Dobretsov M; Crooks PA; Fantegrossi WE
Pharmacol Res Perspect; 2018 Jul; 6(4):e00403. PubMed ID: 29930811
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and Transporters.
Torralva R; Eshleman AJ; Swanson TL; Schmachtenberg JL; Schutzer WE; Bloom SH; Wolfrum KM; Reed JF; Janowsky A
J Pharmacol Exp Ther; 2020 Sep; 374(3):376-391. PubMed ID: 32513839
[TBL] [Abstract][Full Text] [Related]
20. Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.
Harland AA; Yeomans L; Griggs NW; Anand JP; Pogozheva ID; Jutkiewicz EM; Traynor JR; Mosberg HI
J Med Chem; 2015 Nov; 58(22):8952-69. PubMed ID: 26524472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
